JZP258 (XYWAV)
JZP258-407
Approved small_molecule completed
Quick answer
JZP258 (XYWAV) for Idiopathic Hypersomnia is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Idiopathic Hypersomnia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed